United Patients Group

AUGUST 22, 2023

Enter microdosing, an innovative method that entails consuming small amounts of cannabis in sub-psychoactive doses to maximize therapeutic benefits while minimizing undesired side effects or intoxication. Now, microdosing is making its way into the realm of medical marijuana as well.

Microdosing 81

Microdosing Patients THC Tincture 81

Cannabis Law Report

JULY 13, 2022

The proposed phase I dosing study will aim to find the optimal microdose or low dose of psilocybin that provides general enhancements to mood, memory, sleep, and other measures of general well-being without any hallucinogenic effects. VANCOUVER, British Columbia, July 13, 2022 (GLOBE NEWSWIRE) — Optimi Health Corp. (

Therapy 52

Therapy Clinical Trials Microdosing Research and Development 52

The Cannigma

DECEMBER 12, 2022

What is microdosing? A microdose is a dose that does not elicit a perceivable intoxicating or trip-like effect. At most, a mood boost should be all that is felt, and if any visual or auditory effects are noticeable then the dose is not, by definition, a microdose. Everyone is different. 19 20 21 22 23.

History 119

History Microdosing Research and Development Clinical Trials 119

Cannabis Law Report

AUGUST 23, 2022

(CSE: SILO) (OTCQB: SILFF) (FSE: 3K7A) (“Silo Wellness” or the “Company”), a leading global psychedelics company, is pleased to announce that it has opened its first ecotourism microdosing psilocybin resort and retreat center at Go Natural Jamaica in Long Bay, Portland, Jamaica. gram microdose.

Microdosing 52

Microdosing Therapy Media Conditions 52

The Cannigma

FEBRUARY 3, 2022

We find out how women and other estrogen-predominant people react differently to cannabis than men and those with more testosterone, and why microdosing is far more effective for the former. MB: Right and it was a safety consideration and it’s seemed like a good idea. HD: Thanks and thank you for having me on here.

Wellness and Beauty 109

Wellness and Beauty Patients Medicine Cannabis 109

Cannabis Law Report

JUNE 4, 2021

David John Nutt is an English neuropsychopharmacologist specialising in the research of drugs that affect the brain and conditions such as addiction, anxiety, and sleep. Paul is the author of the book Microdosing Psychedelics: A Practical Guide to Upgrade Your Life and the founder and CEO of Third Wave and co-founder of Synthesis.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51